Independent study: CARB-X-supported antibiotic projects are five times more likely to reach clinical trials

An independent, peer-reviewed study published in Health Affairs Scholar found that CARB-X, a global push incentive for antimicrobial resistance (AMR), significantly accelerates the development of life-saving antibiotics. Projects supported by CARB-X have nearly five times greater